Results 31 to 40 of about 31,195 (193)

Identification of Novel tet(X3) Variants Resistant To Tigecycline in Acinetobacter Species

open access: yesMicrobiology Spectrum, 2022
The emergence of the tet(X) gene is a severe challenge to global public health security, as clinical tigecycline resistance shows a rapidly rising trend. In this research, we identified two tigecycline-resistant Acinetobacter sp. strains containing seven
Yumeng Cheng   +5 more
doaj   +1 more source

The Rapid Emergence of Tigecycline Resistance in blaKPC–2 Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment

open access: yesFrontiers in Microbiology, 2018
Tigecycline is one of the last resort treatments for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. Tigecycline resistance often occurs during the clinical treatment of CRKP, yet its mechanism has still not been clearly elucidated.
Xiaoxing Du   +6 more
doaj   +1 more source

Tigecycline efflux as a mechanism for nonsusceptibility in acinetobacter baumannii [PDF]

open access: yes, 2007
Tigecycline has an extended spectrum of in vitro antimicrobial activities, including that against multidrug-resistant Acinetobacter. After identifying bloodstream isolates of Acinetobacter with reduced susceptibilities to tigecycline, we performed a ...
Adams, Jennifer   +2 more
core   +1 more source

Defeating Multidrug‐Resistant ESKAPEE Pathogens With Polymer Nanomaterials

open access: yesAdvanced Science, EarlyView.
Antimicrobial resistance, particularly among ESKAPEE pathogens, represents a major global health threat and drives the need for innovative treatments. Polymer‐based strategies offer promising alternatives to conventional antibiotics by overcoming resistance mechanisms.
Thu Ba Tô   +4 more
wiley   +1 more source

Do bacteria isolated from ICU patients ‘ESKAPE’ antibiotic treatment? In vitro susceptibility of the Enterobacteriaceae family to tigecycline [PDF]

open access: yes, 2017
Background: Enterobacteriaceae are currently causing the majority of healthcare-associated infections (HAI) andsimultaneously expressing increasing levels of antibiotic resistance.
Talaga-Ćwiertnia, Katarzyna; Department of Mycology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland   +8 more
core   +1 more source

Heteroresistance is associated with mutations during low concentration of tigecycline therapy in multiple-resistant Klebsiella pneumoniae

open access: yesAnnals of Clinical Microbiology and Antimicrobials
Background Heteroresistance can lead to treatment failure and has brought a rigorous challenge to clinical laboratories for detecting them. The aim of this study was to investigate the potential for tigecycline-susceptible Klebsiella pneumoniae (K ...
Qiaoyu Zhang   +5 more
doaj   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki   +3 more
wiley   +1 more source

First emergence of acrAB and oqxAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. [PDF]

open access: yesPLoS ONE, 2014
Tigecycline is one of the few therapeutic options for treating infections caused by some multi-drug resistant pathogens, such as Klebsiella pneumoniae. However, tigecycline-resistant K. pneumoniae has been discovered recently in China. From 2009 to 2013,
Xue Zhong   +5 more
doaj   +1 more source

Illuminating Streptomyces: Raman Spectroscopy for Antibiotic Detection and Monitoring

open access: yesJournal of Raman Spectroscopy, EarlyView.
Raman spectroscopy provides a non‐destructive, label‐free approach for studying the chemical diversity of Streptomyces. This review presents its application from detection to chemical characterization of secondary metabolites and monitoring of biosynthetic processes.
Adéla Mikulová   +6 more
wiley   +1 more source

Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia

open access: yes, 2023
Yuanchao Zhu, Fei Zhao, Pengfei Jin Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual
Zhu Y, Zhao F, Jin P
core  

Home - About - Disclaimer - Privacy